Evidence map›Paper›PMID 25938949›Full record

ArticleJournal of visualized experiments : JoVE2015

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.

Russell K Pachynski, Alexander Scholz, Justin Monnier, Eugene C Butcher, Brian A Zabel

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect.Molecular therapy. Nucleic acids · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. ASN neuro
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Russell K PachynskiDivision of Oncology, Department of Medicine, Washington University School of Medicine; rkpachynski@gmail.com.
Alexander ScholzLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine.
Justin MonnierPalo Alto Institute for Research and Education, Veterans Affairs Palo Alto Health Care System; Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine.
Eugene C ButcherLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine.
Brian A ZabelPalo Alto Institute for Research and Education, Veterans Affairs Palo Alto Health Care System.

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
TRAINING PROGRAM IN INVESTIGATIVE ONCOLOGYT32CA009287 · NCI · STANFORD UNIVERSITY · PI FORD, JAMES M. · 1985 to 2012
$4.6M
Intestinal Lymphocyte TraffickingR37AI047822 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2011 to 2020
$3.5M
Molecular and Functional Characterization of Chemerin ReceptorsR01AI079320 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI ZABEL, BRIAN A. · 2009 to 2013
$1.7M
Chemerin in Tumor Immunity and SurveillanceR01CA169354 · NCI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA169354NCI NIH HHS R01-CA169354NCI NIH HHS T32 CA009287NCI NIH HHS T32 CA009287-30A1NIAID NIH HHS AI079320NIAID NIH HHS R01 AI079320NIAID NIH HHS R37 AI047822NIAID NIH HHS T32 AI007290NIAID NIH HHS T32-AI07290-24NIAID NIH HHS T32-AI07290- 25PHS HHS R01-047822
6 · The paper itself

Abstract

Specialized immune cells that infiltrate the tumor microenvironment regulate the growth and survival of neoplasia.  Malignant cells must elude or subvert anti-tumor immune responses in order to survive and flourish. Tumors take advantage of a number of different mechanisms of immune "escape," including the recruitment of tolerogenic DC, immunosuppressive regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSC) that inhibit cytotoxic anti-tumor responses. Conversely, anti-tumor effector immune cells can slow the growth and expansion of malignancies: immunostimulatory dendritic cells, natural killer cells which harbor innate anti-tumor immunity, and cytotoxic T cells all can participate in tumor suppression. The balance between pro- and anti-tumor leukocytes ultimately determines the behavior and fate of transformed cells; a multitude of human clinical studies have borne this out. Thus, detailed analysis of leukocyte subsets within the tumor microenvironment has become increasingly important. Here, we describe a method for analyzing infiltrating leukocyte subsets present in the tumor microenvironment in a mouse tumor model. Mouse B16 melanoma tumor cells were inoculated subcutaneously in C57BL/6 mice. At a specified time, tumors and surrounding skin were resected en bloc and processed into single cell suspensions, which were then stained for multi-color flow cytometry. Using a variety of leukocyte subset markers, we were able to compare the relative percentages of infiltrating leukocyte subsets between control and chemerin-expressing tumors. Investigators may use such a tool to study the immune presence in the tumor microenvironment and when combined with traditional caliper size measurements of tumor growth, will potentially allow them to elucidate the impact of changes in immune composition on tumor growth. Such a technique can be applied to any tumor model in which the tumor and its microenvironment can be resected and processed.

Indexed as

AnimalsDisease Models, AnimalFemaleFlow CytometryKiller Cells, NaturalLeukocytesLymphocytes, Tumor-InfiltratingMelanoma, ExperimentalMiceMice, Inbred C57BLT-Lymphocytes, CytotoxicT-Lymphocytes, RegulatoryTumor Microenvironment

Identifiers

PMID25938949
PMCPMC4541547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.